The conversation delves into the replication crisis in Alzheimer's research, highlighting how flawed findings can lead to ineffective treatments. Both Andrew and Jay emphasize that while data manipulation is a concern, the larger issue lies in the systemic incentives that drive scientists to prioritize quantity over quality in their research. This structural problem has led to significant consequences in the field, ultimately affecting patient care and trust in scientific findings.
